Cargando…

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives

Obesity and obesity-associated disorders pose a major public health issue worldwide. Apart from conventional weight loss drugs, next-generation probiotics (NGPs) seem to be very promising as potential preventive and therapeutic agents against obesity. Candidate NGPs such as Akkermansia muciniphila,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallianou, Natalia G., Kounatidis, Dimitris, Tsilingiris, Dimitrios, Panagopoulos, Fotis, Christodoulatos, Gerasimos Socrates, Evangelopoulos, Angelos, Karampela, Irene, Dalamaga, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095285/ https://www.ncbi.nlm.nih.gov/pubmed/37047729 http://dx.doi.org/10.3390/ijms24076755

Ejemplares similares

Mycobiome and Cancer: What Is the Evidence?
por: Vallianou, Natalia, et al.
Publicado: (2021)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
por: Dalamaga, Maria, et al.
Publicado: (2021)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2023)

Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients
por: Karampela, Irene, et al.
Publicado: (2023)

Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study
por: Karampela, Irene, et al.
Publicado: (2022)

Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices
por: Vallianou, Natalia G., et al.
Publicado: (2023)

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health
por: Karampela, Irene, et al.
Publicado: (2022)

Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence
por: Vallianou, Natalia, et al.
Publicado: (2021)

Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study
por: Christodoulatos, Gerasimos Socrates, et al.
Publicado: (2021)

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
por: Amanatidou, Evropi, et al.
Publicado: (2022)

SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?
por: Kounatidis, Dimitris, et al.
Publicado: (2023)

Prediabetes screening: Questionable benefits in the golden years
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Of mice and men: Considerations on adipose tissue physiology in animal models of obesity and human studies()
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasis
por: Dalamaga, Maria, et al.
Publicado: (2019)

Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Cardiac MRI in Autoimmune Diseases: Where Are We Now?
por: Vallianou, Natalia G., et al.
Publicado: (2021)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

The non-linear relationship between muscle mass and BMI calls into question the use of BMI as a major criterion for eligibility for bariatric surgery
por: Liu, Junli, et al.
Publicado: (2022)

Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?
por: Karampela, Irene, et al.
Publicado: (2019)

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
por: Karampela, Irene, et al.
Publicado: (2020)

Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsis
por: Karampela, Irene, et al.
Publicado: (2021)

Does COVID-19 Involve the Retina?
por: Karampelas, Michael, et al.
Publicado: (2020)

Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
por: Dalamaga, Maria, et al.
Publicado: (2020)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?
por: Vallianou, Natalia, et al.
Publicado: (2019)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Vertebral osteomyelitis and native valve endocarditis due to Staphylococcus simulans: a case report
por: Vallianou, Natalia, et al.
Publicado: (2008)

Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives
por: Fotis, Dimitrios, et al.
Publicado: (2022)

Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics
por: Breton, Jonathan, et al.
Publicado: (2022)

Obesity and gut microbiome: review of potential role of probiotics
por: Schütz, Francine, et al.
Publicado: (2021)

Obesity: A pandemic hidden in the Covid-19 pandemic
por: Evangelou, K., et al.
Publicado: (2022)

Perspectives and Challenges of COVID-19 with Obesity-Related Cancers
por: Dalamaga, Maria, et al.
Publicado: (2023)

Colonic flora, Probiotics, Obesity and Diabetes
por: Marik, Paul E.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dhbeqdae1n128jun9m4i3fs67j